On October 12, Pfizer announced that with the approval of the State Drug Administration, enoglutide injections will increase the indications for type 2 diabetes in adults.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.